Contribution of the MHC region to the familial risk of coeliac disease.

PubWeight™: 1.20‹?› | Rank: Top 10%

🔗 View Article (PMC 1734425)

Published in J Med Genet on September 01, 1999

Authors

S Bevan1, S Popat, C P Braegger, A Busch, D O'Donoghue, K Falth-Magnusson, A Ferguson, A Godkin, L Hogberg, G Holmes, K B Hosie, P D Howdle, H Jenkins, D Jewell, S Johnston, N P Kennedy, G Kerr, P Kumar, R F Logan, A H Love, M Marsh, C J Mulder, K Sjoberg, L Stenhammer, J Walker-Smith, A M Marossy, R S Houlston

Author Affiliations

1: Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey.

Articles citing this

The first large population based twin study of coeliac disease. Gut (2002) 1.91

The spectrum of celiac disease: epidemiology, clinical aspects and treatment. Nat Rev Gastroenterol Hepatol (2010) 1.77

Replication of celiac disease UK genome-wide association study results in a US population. Hum Mol Genet (2009) 1.39

HLA DQ gene dosage and risk and severity of celiac disease. Clin Gastroenterol Hepatol (2007) 1.22

The immune recognition of gluten in coeliac disease. Clin Exp Immunol (2005) 1.10

Genomewide linkage analysis of celiac disease in Finnish families. Am J Hum Genet (2001) 1.03

Interplay between genetics and the environment in the development of celiac disease: perspectives for a healthy life. J Clin Invest (2001) 0.90

Immune development and intestinal microbiota in celiac disease. Clin Dev Immunol (2012) 0.90

Translational mini-review series on the immunogenetics of gut disease: immunogenetics of coeliac disease. Clin Exp Immunol (2008) 0.90

Lack of association of MYO9B genetic variants with coeliac disease in a British cohort. Gut (2006) 0.88

Serological assessment for celiac disease in IgA deficient adults. PLoS One (2014) 0.85

Novel therapeutic/integrative approaches for celiac disease and dermatitis herpetiformis. Clin Dev Immunol (2012) 0.85

Analysis of the expression of MICA in small intestinal mucosa of patients with celiac disease. J Clin Immunol (2003) 0.82

Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases. Inflamm Bowel Dis (2016) 0.80

Origin of celiac disease: how old are predisposing haplotypes? World J Gastroenterol (2012) 0.79

Meta-analysis of genome-wide linkage studies in celiac disease. Hum Hered (2009) 0.79

Pathogenesis of coeliac disease: implications for treatment. World J Gastroenterol (2001) 0.79

Frequency distribution of HLA DQ2 and DQ8 in celiac patients and first-degree relatives in Recife, northeastern Brazil. Clinics (Sao Paulo) (2011) 0.79

Interleukin-10 haplotypes in Celiac Disease in the Spanish population. BMC Med Genet (2006) 0.79

The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet. Semin Immunopathol (2012) 0.78

Common polygenic variation in coeliac disease and confirmation of ZNF335 and NIFA as disease susceptibility loci. Eur J Hum Genet (2015) 0.78

Important lessons derived from animal models of celiac disease. Int Rev Immunol (2011) 0.78

Linkage analysis of HLA and candidate genes for celiac disease in a North American family-based study. BMC Med Genet (2001) 0.77

DQ2, DQ7 and DQ8 Distribution and Clinical Manifestations in Celiac Cases and Their First-Degree Relatives. Nutrients (2015) 0.76

Hepatobiliary disorders in celiac disease: an update. Int J Hepatol (2010) 0.75

Allelic frequencies of the hs1.2 enhancer within the immunoglobulin heavy chain region in Dayton, Ohio patients screened for celiac disease with duodenal biopsy. Dig Liver Dis (2017) 0.75

Articles cited by this

Complete multipoint sib-pair analysis of qualitative and quantitative traits. Am J Hum Genet (1995) 12.78

Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology (1992) 10.44

Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet (1990) 9.48

Coeliac disease in the year 2000: exploring the iceberg. Lancet (1994) 6.05

Incidence of coeliac disease in the West of Ireland. Br Med J (1973) 3.12

Predominance of histocompatibility antigen HL-A8 in patients with gluten-sensitive enteropathy. J Clin Invest (1972) 3.09

Changes in clinical features of coeliac disease in adults in Edinburgh and the Lothians 1960-79. Br Med J (Clin Res Ed) (1983) 2.91

HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology (1993) 2.72

Prevalence and "incidence" of celiac disease in Edinburgh and the Lothian region of Scotland. Gastroenterology (1986) 2.34

Genetics of coeliac disease. QJM (1996) 1.90

HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. Gut (1983) 1.65

The subtle and variable clinical expressions of gluten-induced enteropathy (adult celiac disease, nontropical sprue). An analysis of twenty-one consecutive cases. Am J Med (1970) 1.64

Genetic basis of gluten-sentitive enteropathy. Gastroenterology (1978) 1.60

Evidence for recessive and against dominant inheritance at the HLA-"linked" locus in coeliac disease. Am J Hum Genet (1982) 1.54

Adult coeliac disease within a defined geographic area in Sweden. A study of prevalence and associated diseases. Scand J Gastroenterol (1988) 1.42

Genetic contribution of the HLA region to the familial clustering of coeliac disease. Ann Hum Genet (1997) 1.34

High prevalence of celiac disease in healthy adults revealed by antigliadin antibodies. Ann Allergy (1992) 1.25

Genome search in celiac disease. Am J Hum Genet (1998) 1.14

Family and population studies of HLA and coeliac disease in the West of Ireland. Tissue Antigens (1983) 1.08

Unchanging clinical picture of coeliac disease presentation in Campania, Italy. Eur J Pediatr (1989) 0.99

HLA and coeliac disease. Br Med Bull (1978) 0.96

HLA and diseases: involvement of more than one HLA-linked determinant of disease susceptibility. Immunol Rev (1983) 0.88

A family study confirms that the HLA-DP associations with celiac disease are the result of an extended HLA-DR3 haplotype. Hum Immunol (1991) 0.83

HLA-DR antigens and phenotypes in Dutch coeliac children and their families. Clin Genet (1985) 0.83

HLA-DP and coeliac disease: family and population studies. Gut (1990) 0.81

Evidence for a dominant gene mechanism underlying coeliac disease in the west of Ireland. Genet Epidemiol (1991) 0.81

Immunogenetics of childhood celiac disease: the association with HDA DR3 and DR7 in unrelated patients with multiply affected families. Isr J Med Sci (1981) 0.79

Articles by these authors

DISTURBANCES OF VISION BY CEREBRAL LESIONS. Br J Ophthalmol (1918) 8.56

Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol (2005) 8.15

Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science (1998) 7.08

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet (1994) 6.89

CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell (1996) 6.52

Kuppuswamy's socioeconomic status scale-updating for 2007. Indian J Pediatr (2007) 6.26

Quantitation of intraepithelial lymphocytes in human jejunum. Gut (1971) 6.18

Breast augmentation: a risk factor for breast cancer? N Engl J Med (1992) 6.11

Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ (1995) 5.98

Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J Exp Med (1998) 5.78

Frequency of "functional" gastrointestinal disorders. Lancet (1977) 5.73

Penetration of Semliki Forest virus from acidic prelysosomal vacuoles. Cell (1983) 5.46

Risk assessment after acute upper gastrointestinal haemorrhage. Gut (1996) 5.02

Adsorptive endocytosis of Semliki Forest virus. J Mol Biol (1980) 4.94

Acidification of macrophage and fibroblast endocytic vesicles in vitro. Proc Natl Acad Sci U S A (1983) 4.65

A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol (2001) 4.61

Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage. National Audit of Acute Upper Gastrointestinal Haemorrhage. Lancet (1996) 4.55

Policy alternatives for resource allocation. Lancet (1977) 4.52

Human immunodeficiency virus infection of CD4-bearing cells occurs by a pH-independent mechanism. EMBO J (1988) 3.98

Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol (1999) 3.84

DISTURBANCES OF VISUAL ORIENTATION. Br J Ophthalmol (1918) 3.82

The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion? AIDS Res Hum Retroviruses (1991) 3.78

The pH independence of mammalian retrovirus infection. J Gen Virol (1990) 3.68

Coeliac disease in primary care: case finding study. BMJ (1999) 3.60

Glycoproteins of the lysosomal membrane. J Cell Biol (1985) 3.46

Transient gluten intolerance. Arch Dis Child (1970) 3.45

A quantitative analysis of the endocytic pathway in baby hamster kidney cells. J Cell Biol (1989) 3.41

Similarities in intestinal humoral immunity in dermatitis herpetiformis without enteropathy and in coeliac disease. Lancet (1990) 3.37

Cholesterol solubility in bile. Evidence that supersaturated bile is frequent in healthy man. J Clin Invest (1973) 3.34

Recommendations for standards of sedation and patient monitoring during gastrointestinal endoscopy. Gut (1991) 3.27

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study. Health Technol Assess (2003) 3.25

Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut (1993) 3.25

Intraepithelial lymphocytes of the small intestine. Gut (1977) 3.21

Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa. Immunology (1993) 3.20

Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. BMJ (1992) 3.17

Sedation for upper gastrointestinal endoscopy: results of a nationwide survey. Gut (1991) 3.14

The effect of anticoagulant choice on apparent total antioxidant capacity using three different methods. Ann Clin Biochem (1995) 3.10

Inhibition of Semliki forest virus penetration by lysosomotropic weak bases. J Gen Virol (1982) 3.10

The effect of antigen deprivation on thymus-dependent and thymus-independent lymphocytes in the small intestine of the mouse. Clin Exp Immunol (1972) 3.09

Selective migration of lymphocytes within the mouse small intestine. Immunology (1974) 3.06

Household products and poisoning. Br Med J (1978) 3.03

A population of fast radio bursts at cosmological distances. Science (2013) 3.03

Randomized controlled trial of intraoperative goal-directed fluid therapy in aerobically fit and unfit patients having major colorectal surgery. Br J Anaesth (2011) 3.01

Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain (2008) 2.99

A critical review of adaptive genetic variation in Atlantic salmon: implications for conservation. Biol Rev Camb Philos Soc (2007) 2.98

Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis. Gut (2007) 2.97

Role of angiogenesis in patients with cerebral ischemic stroke. Stroke (1994) 2.96

What's happening to practice nursing? BMJ (1994) 2.96

Changes in clinical features of coeliac disease in adults in Edinburgh and the Lothians 1960-79. Br Med J (Clin Res Ed) (1983) 2.91

Future specialization interests among medical students in southern India. Natl Med J India (2013) 2.91

Urgency and priority for cardiac surgery: a clinical judgment analysis. BMJ (1998) 2.90

Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study. Endoscopy (2007) 2.88

Base excess and lactate as prognostic indicators for patients admitted to intensive care. Intensive Care Med (2001) 2.86

The entry of enveloped viruses into cells by endocytosis. Biochem J (1984) 2.83

Three-dimensional structure of endosomes in BHK-21 cells. Proc Natl Acad Sci U S A (1986) 2.81

Food and medicaments as possible sources of hospital strains of Pseudomonas aeruginosa. Lancet (1969) 2.79

Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity. J Exp Med (1998) 2.76

Pilot study of high-sensitivity troponin T testing to facilitate safe early disposition decisions in patients presenting to the emergency department with chest pain. Intern Med J (2009) 2.68

Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology (1998) 2.68

14C-urea breath analysis, a non-invasive test for Campylobacter pylori in the stomach. Lancet (1987) 2.68

Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol (2001) 2.64

Perforating eye injuries: a five year survey. Trans Ophthalmol Soc U K (1971) 2.63

Management of labour in an isolated rural maternity hospital. BMJ (1996) 2.63

Prevention of hypoxaemia during upper-gastrointestinal endoscopy by means of oxygen via nasal cannulae. Lancet (1987) 2.60

A comparison of budesonide with prednisolone for active Crohn's disease. N Engl J Med (1994) 2.58

Subclavian artery laceration and acute hemothorax on attempted internal jugular vein cannulation. J Cardiothorac Vasc Anesth (1991) 2.58

High-level expression of M13 gene II protein from an inducible polycistronic messenger RNA. Gene (1985) 2.56

A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group. N Engl J Med (1998) 2.54

Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med (1995) 2.52

Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. Gut (2009) 2.50

Immunological responses to fed protein antigens in mice. I. Reversal of oral tolerance to ovalbumin by cyclophosphamide. Immunology (1982) 2.50

Evaluation of a nurse-run hypertension clinic in general practice. Practitioner (1988) 2.49

Diagnosis and treatment of enterovesical fistulae. Colorectal Dis (2005) 2.48

Monensin inhibits Semliki Forest virus penetration into culture cells. Proc Natl Acad Sci U S A (1982) 2.46

Platinum-based chemotherapy in triple-negative breast cancer. Ann Oncol (2008) 2.46

Intestinal inflammation in cystic fibrosis. Arch Dis Child (2000) 2.46

Primary small-bowel malignancy in the UK and its association with coeliac disease. QJM (2003) 2.45

Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology (1994) 2.45

Too many patients, too few cardiologists to care? Can J Cardiol (2006) 2.45

Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet (2001) 2.44

The effects of different component response requirements in multiple and concurrent schedules. J Exp Anal Behav (1978) 2.43

Double-balloon enteroscopy: indications, diagnostic yield, and complications in a series of 275 patients with suspected small-bowel disease. Endoscopy (2006) 2.43

Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent. J Virol (1997) 2.42

Cell-mediated immunity to gliadin within the small-intestinal mucosa in coeliac disease. Lancet (1975) 2.41

Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease. Lancet (1997) 2.38

Intravenous midazolam: a study of the degree of oxygen desaturation occurring during upper gastrointestinal endoscopy. Br J Clin Pharmacol (1987) 2.36

What is value for money in medical care? Experiences in England and Wales, Sweden, and the U. S. A. Lancet (1967) 2.36

Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. J Cell Biol (1997) 2.35

A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells. J Virol (1995) 2.35

Identification of the cystic fibrosis gene. BMJ (1990) 2.34

The natural history of untreated dorsal wrist ganglia and patient reported outcome 6 years after intervention. J Hand Surg Eur Vol (2007) 2.34

Prevalence and "incidence" of celiac disease in Edinburgh and the Lothian region of Scotland. Gastroenterology (1986) 2.34

Rapid analytical and preparative isolation of functional endosomes by free flow electrophoresis. J Cell Biol (1987) 2.33

Interobserver agreement in grading of colorectal cancers-findings from a nationwide web-based survey of histopathologists. Histopathology (2008) 2.32

Intraepithelial cells in the human intestinal mucosa. J Ultrastruct Res (1971) 2.31